Form 4: BeiGene SVP, General Counsel Chan Henry Lee Sells American Depositary Shares
SEC Form 4 Filing
Chan Henry Lee, SVP and General Counsel of BeiGene, Ltd., sold 1,202 American Depositary Shares on September 30, 2024, at a price of $237.10 per share, according to a Form 4 filing with the SEC.
Summary
- On September 30, 2024, Chan Henry Lee, the SVP and General Counsel of BeiGene, Ltd., sold 1,202 American Depositary Shares (ADS).
- The sale was executed at a price of $237.10 per ADS.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 9, 2023, and amended on February 28, 2024.
- Following the transaction, Lee directly owns 237,224 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an insider sale. It doesn't inherently convey positive or negative sentiment, as it's a factual report of a transaction.
Industry Context
Insider sales are a common occurrence in publicly traded companies and are often related to personal financial planning. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by an insider could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2023-05-09 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-02-28 | Date of amendment of Rule 10b5-1 trading plan |
| 2024-09-30 | Date of transaction (sale of American Depositary Shares) |
| 2024-10-02 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.